Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Voyager Therapeutics (VYGR) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Voyager Therapeutics (VYGR) over the last 11 years, with Q3 2025 value amounting to $34.9 million.

  • Voyager Therapeutics' Cash from Investing Activities fell 4578.57% to $34.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $50.8 million, marking a year-over-year increase of 22448.62%. This contributed to the annual value of -$94.9 million for FY2024, which is 3302.95% up from last year.
  • According to the latest figures from Q3 2025, Voyager Therapeutics' Cash from Investing Activities is $34.9 million, which was down 4578.57% from $1.9 million recorded in Q2 2025.
  • Voyager Therapeutics' 5-year Cash from Investing Activities high stood at $64.4 million for Q3 2024, and its period low was -$158.3 million during Q3 2023.
  • Over the past 5 years, Voyager Therapeutics' median Cash from Investing Activities value was $14.1 million (recorded in 2022), while the average stood at -$5.3 million.
  • As far as peak fluctuations go, Voyager Therapeutics' Cash from Investing Activities surged by 131898.8% in 2021, and later tumbled by 76292.87% in 2024.
  • Quarter analysis of 5 years shows Voyager Therapeutics' Cash from Investing Activities stood at -$5.5 million in 2021, then soared by 357.45% to $14.1 million in 2022, then soared by 90.75% to $26.8 million in 2023, then crashed by 201.38% to -$27.2 million in 2024, then skyrocketed by 228.25% to $34.9 million in 2025.
  • Its last three reported values are $34.9 million in Q3 2025, $1.9 million for Q2 2025, and $41.2 million during Q1 2025.